Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000053417-15-000135
Filing Date
2015-02-10
Accepted
2015-02-10 16:28:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G FINAL ANNUAL FILING - VRTX vrtx1214.txt SC 13G/A 7146
  Complete submission text file 0000053417-15-000135.txt   8675
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

EIN.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Subject) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42126 | Film No.: 15594253
SIC: 2834 Pharmaceutical Preparations